​

ORIC Pharmaceuticals Ownership | Who Owns ORIC Pharmaceuticals?

OverviewForecastRevenueFinancialsChart

ORIC Pharmaceuticals Ownership Summary

ORIC Pharmaceuticals is owned by 119.47% institutional investors, 6.94% insiders. Vr adviser is the largest institutional shareholder, holding 8.44% of ORIC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.65% of its assets in ORIC Pharmaceuticals shares.

ORIC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockORIC Pharmaceuticals119.47%6.94%-26.40%
SectorHealthcare Stocks 488.30%11.08%-399.38%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vr adviser6.60M8.44%$66.96M
Viking global investors lp6.57M8.41%$66.71M
Nextech invest5.29M7.49%$42.66M
Blackrock4.83M7.17%$34.15M
Pfizer5.38M6.88%$54.57M
Alkeon capital management4.50M5.77%$45.72M
Nea management company4.12M5.27%$41.80M
Blackrock funding, inc. /de4.08M5.22%$41.39M
Column group3.54M5.02%$28.57M
Ecor1 capital3.42M4.85%$27.58M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Column group3.54M51.26%$28.57M
Pfizer5.38M9.47%$54.57M
Invus financial advisors1.01M7.98%$7.12M
Nextech invest5.29M6.92%$42.66M
Vr adviser6.60M5.02%$66.96M
Superstring capital management lp344.92K4.15%$3.50M
Ally bridge group (ny)485.63K4.10%$4.93M
Silverarc capital management1.80M3.37%$18.28M
Euclidean capital989.41K3.28%$10.04M
Vivo capital3.13M3.25%$31.74M

Top Buyers

HolderShares% AssetsChange
Vr adviser6.60M5.02%3.41M
Point72 asset management2.85M0.06%2.85M
Nea management company4.12M3.15%1.92M
Blackrock4.83M0.00%1.65M
Integral health asset management1.25M1.16%1.25M

Top Sellers

HolderShares% AssetsChange
Commodore capital lp---2.00M
Fmr2.47M0.00%-1.91M
Blackrock funding, inc. /de4.08M0.00%-1.36M
Avidity partners management lp---1.27M
Ubs asset management americas---509.18K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management2.85M0.06%2.85M$28.93M
Integral health asset management1.25M1.16%1.25M$12.69M
Eventide asset management951.43K0.17%951.43K$9.66M
Ally bridge group (ny)485.63K4.10%485.63K$4.93M
Royce & associates lp234.77K0.02%234.77K$2.38M

Sold Out

HolderChange
Capital performance advisors llp-1.00
Nelson, van denburg & campbell wealth management group-8.00
True wealth design-26.00
Coldstream capital management-45.00
Parkside financial bank & trust-50.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025143-0.69%93,335,02017.83%1190.96%75-8.54%5236.84%
Mar 31, 202511-91.91%11,102,130-85.35%150.14%8-89.87%2-92.86%
Dec 31, 202439-68.29%10,134,721-85.49%140.15%26-58.06%7-81.58%
Sep 30, 202412310.81%69,828,6523.33%980.98%62-16.22%38100.00%
Jun 30, 2024111-2.63%67,581,2495.85%1001.12%7410.45%19-32.14%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.88M2.65%-
ACAP Strategic A2.23M2.29%244.72K
Vanguard Total Stock Mkt Idx Inv1.90M2.20%-42.04K
Fidelity Growth Compy Commingled Pl O1.28M1.81%-
Fidelity Growth Compy Commingled Pl S1.31M1.35%1.34K
iShares Russell 2000 ETF1.10M1.13%-
US Small-Cap Growth II Equity Comp914.12K1.07%914.12K
Eventide Healthcare & Life Sciences I951.43K0.98%951.43K
T. Rowe Price Health Sciences925.93K0.95%-102.51K
Fidelity Advisor Biotechnology I581.72K0.82%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 06, 2025Piscitelli Dominic Chief Financial OfficerSell$159.72K
Oct 06, 2025Chacko Jacob PRESIDENT AND CEOSell$461.52K
Oct 01, 2025Chacko Jacob PRESIDENT AND CEOSell$638.81K
Sep 30, 2025Chacko Jacob PRESIDENT AND CEOSell$414.75K
Sep 22, 2025Chacko Jacob PRESIDENT AND CEOSell$1.35M

Insider Transactions Trends

DateBuySell
2025 Q4-3
2025 Q3-3
2025 Q229
2025 Q1--
2024 Q4-3

ORIC Ownership FAQ

Who Owns ORIC Pharmaceuticals?

ORIC Pharmaceuticals shareholders are primarily institutional investors at 119.47%, followed by 6.94% insiders and -26.41% retail investors. The average institutional ownership in ORIC Pharmaceuticals's industry, Biotech Stocks , is 307.10%, which ORIC Pharmaceuticals falls below.

Who owns the most shares of ORIC Pharmaceuticals?

ORIC Pharmaceuticals’s largest shareholders are Vr adviser (6.6M shares, 8.44%), Viking global investors lp (6.57M shares, 8.41%), and Nextech invest (5.29M shares, 7.49%). Together, they hold 24.35% of ORIC Pharmaceuticals’s total shares outstanding.

Does Blackrock own ORIC Pharmaceuticals?

Yes, BlackRock owns 7.17% of ORIC Pharmaceuticals, totaling 4.83M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 34.15M$. In the last quarter, BlackRock increased its holdings by 1.65M shares, a 52.00% change.

Who is ORIC Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Column group is ORIC Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 51.26% of its assets in 3.54M ORIC Pharmaceuticals shares, valued at 28.57M$.

Who is the top mutual fund holder of ORIC Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of ORIC Pharmaceuticals shares, with 2.65% of its total shares outstanding invested in 1.88M ORIC Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools